PMEF
Point72 Middle East FZE Portfolio holdings
AUM
$1.44B
1-Year Return
6.39%
This Quarter Return
+5.25%
1 Year Return
+6.39%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.3B
AUM Growth
–
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
10.49%
Holding
1,359
New
1,291
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
S&P Global
SPGI
|
+$16.5M |
| 2 |
American International
AIG
|
+$15.4M |
| 3 |
Advanced Micro Devices
AMD
|
+$15.3M |
| 4 |
Merck
MRK
|
+$14M |
| 5 |
Broadcom
AVGO
|
+$13.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 17.91% |
| 2 | Consumer Discretionary | 16.18% |
| 3 | Financials | 14.39% |
| 4 | Healthcare | 14.18% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSVT
801
DELISTED
2seventy bio
TSVT
| $82.8K | ﹤0.01% |
+8,832
| New | +$82.8K |
|
802
Vicor
VICR
$2.25B
| $82.6K | ﹤0.01% |
+1,536
| New | +$82.6K |
|
803
Baker Hughes
BKR
$44.8B
| $82.5K | ﹤0.01% |
+2,795
| New | +$82.5K |
|
804
Commerce Bancshares
CBSH
$8.04B
| $82.1K | ﹤0.01% |
+1,330
| New | +$82.1K |
|
805
Rayonier
RYN
$4.04B
| $82K | ﹤0.01% |
+2,616
| New | +$82K |
|
806
Myriad Genetics
MYGN
$649M
| $81.8K | ﹤0.01% |
+5,636
| New | +$81.8K |
|
807
Trustmark
TRMK
$2.41B
| $81.7K | ﹤0.01% |
+2,341
| New | +$81.7K |
|
|
NKLA
808
DELISTED
Nikola Corporation Common Stock
NKLA
| $81.5K | ﹤0.01% |
+1,258
| New | +$81.5K |
|
809
Amicus Therapeutics
FOLD
$2.43B
| $81.4K | ﹤0.01% |
+6,666
| New | +$81.4K |
|
810
Kura Sushi USA
KRUS
$965M
| $81.2K | ﹤0.01% |
+1,702
| New | +$81.2K |
|
|
NOVA
811
DELISTED
Sunnova Energy
NOVA
| $81K | ﹤0.01% |
+4,498
| New | +$81K |
|
812
Udemy
UDMY
$1.03B
| $81K | ﹤0.01% |
+7,677
| New | +$81K |
|
813
Brink's
BCO
$4.82B
| $80.6K | ﹤0.01% |
+1,501
| New | +$80.6K |
|
814
La-Z-Boy
LZB
$1.45B
| $80.2K | ﹤0.01% |
+3,514
| New | +$80.2K |
|
815
Texas Instruments
TXN
$168B
| $79.6K | ﹤0.01% |
+482
| New | +$79.6K |
|
816
Snap-on
SNA
$16.8B
| $79.5K | ﹤0.01% |
+348
| New | +$79.5K |
|
817
Arcturus Therapeutics
ARCT
$487M
| $79.3K | ﹤0.01% |
+4,673
| New | +$79.3K |
|
818
Dine Brands
DIN
$360M
| $78.8K | ﹤0.01% |
+1,220
| New | +$78.8K |
|
819
Fulgent Genetics
FLGT
$683M
| $78.6K | ﹤0.01% |
+2,641
| New | +$78.6K |
|
|
BNFT
820
DELISTED
Benefitfocus, Inc.
BNFT
| $78.2K | ﹤0.01% |
+7,472
| New | +$78.2K |
|
821
Nutanix
NTNX
$20.3B
| $77.4K | ﹤0.01% |
+2,971
| New | +$77.4K |
|
822
Alphatec Holdings
ATEC
$2.34B
| $77.2K | ﹤0.01% |
+6,255
| New | +$77.2K |
|
823
Nektar Therapeutics
NKTR
$924M
| $77K | ﹤0.01% |
+2,272
| New | +$77K |
|
824
Aclaris Therapeutics
ACRS
$231M
| $75.4K | ﹤0.01% |
+4,788
| New | +$75.4K |
|
825
ATI
ATI
$10.3B
| $75.4K | ﹤0.01% |
+2,524
| New | +$75.4K |
|